Tumor-specific immunity and anti-angiogenesis induced by a vaccine encoding calreticulin linked to HPV-16 E7 protein

被引：0
|
作者：
Cheng, WF [1 ]
Hung, CF [1 ]
Hsu, KF [1 ]
Chai, CY [1 ]
He, L [1 ]
Ling, M [1 ]
Wu, TC [1 ]
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
来源：
MODERN PATHOLOGY | 2001年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
784
引用
收藏
页码：134A / 134A
页数：1
相关论文
共 50 条
  • [21] Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors
    Sewell, Duane A.
    Pan, Zhen Kun
    Paterson, Yvonne
    VACCINE, 2008, 26 (41) : 5315 - 5320
  • [22] The HPV-16 E7 oncogene sensitizes malignant cells to IFN-α-induced apoptosis
    Thyrell, L
    Sangfelt, O
    Zhivotovsky, B
    Pokrovskaja, K
    Wang, YS
    Einhorn, S
    Grandér, D
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2005, 25 (02): : 63 - 72
  • [23] DNA vaccine encoding heat shock protein 60 co-linked to HPV 16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens
    Huang, Chia-Yen
    Chen, Chi-An
    Lee, Chien-Nan
    Chang, Ming-Cheng
    Su, Yi-Ning
    Lin, Yi-Chun
    Hsieh, Chang-Yao
    Cheng, Wen-Fang
    GYNECOLOGIC ONCOLOGY, 2007, 107 (03) : 404 - 412
  • [24] Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
    Cheng, W-F
    Lee, C-N
    Su, Y-N
    Chai, C-Y
    Chang, M-C
    Polo, J. M.
    Hung, C-F
    Wu, T-C
    Hsieh, C-Y
    Chen, C-A
    CANCER GENE THERAPY, 2006, 13 (09) : 873 - 885
  • [25] Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity
    W-F Cheng
    C-N Lee
    Y-N Su
    C-Y Chai
    M-C Chang
    J M Polo
    C-F Hung
    T-C Wu
    C-Y Hsieh
    C-A Chen
    Cancer Gene Therapy, 2006, 13 : 873 - 885
  • [26] Antitumor effect of adenoviruses expressing mutant non-oncogenic E7 versions from HPV-16 fused to calreticulin
    Abigail Robles-Rodriguez, Olivia
    Juan Perez-Trujillo, Jose
    Alberto Barron-Cantu, Jose
    Torres-Cerda, Abigail
    Gutierrez-Puente, Yolanda
    Garcia-Garcia, Aracely
    Rodriguez-Rocha, Humberto
    Villanueva-Olivo, Arnulfo
    Zavala-Flores, Laura M.
    Saucedo-Cardenas, Odila
    Montes-de-Oca-Luna, Roberto
    de Jesus Loera-Arias, Maria
    JOURNAL OF BUON, 2020, 25 (01): : 543 - 548
  • [27] Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein
    Di Bonito, Paola
    Grasso, Felicia
    Mochi, Stefania
    Petrone, Linda
    Fanales-Belasio, Emanuele
    Mei, Arianna
    Cesolini, Armando
    Laconi, Giuseppe
    Conrad, Heinke
    Bernhard, Helga
    Dembek, Claudia J.
    Cosma, Antonio
    Santini, Stefano M.
    Lapenta, Caterina
    Donati, Simona
    Muratori, Claudia
    Giorgi, Colomba
    Federico, Maurizio
    VIROLOGY, 2009, 395 (01) : 45 - 55
  • [28] Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques
    Yan, Jian
    Harris, Kristina
    Khan, Amir S.
    Draghia-Akli, Ruxandra
    Sewell, Duane
    Weiner, David B.
    VACCINE, 2008, 26 (40) : 5210 - 5215
  • [29] CONTINUED EXPRESSION OF HPV-16 E7 PROTEIN IS REQUIRED FOR MAINTENANCE OF THE TRANSFORMED PHENOTYPE OF CELLS CO-TRANSFORMED BY HPV-16 PLUS EJ-RAS
    CROOK, T
    MORGENSTERN, JP
    CRAWFORD, L
    BANKS, L
    EMBO JOURNAL, 1989, 8 (02): : 513 - 519
  • [30] HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
    Le Buanec, H
    D'Anna, R
    Lachgar, A
    Zagury, JF
    Bernard, J
    Ittelé, D
    d'Alessio, P
    Hallez, S
    Giannouli, C
    Burny, A
    Bizzini, B
    Gallo, RC
    Zagury, D
    BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (09) : 424 - 431
12345